Feed

Show only
Peter Huber
20/09/2017
CMS Vi­enna Ad­vises Slov­akia-Based Arca Cap­it­al Group...
12 Oct 17
Up­date Bauver­trag­s­recht (Sem­in­ar in Ger­man)
So bauen Sie auf einem recht­lich gesich­er­ten Fun­da­ment
20/09/2017
Pub­lic Coun­try-by-Coun­try Re­port­ing; Tax­pay­er­s' Rights
Ap­pro­pri­ate Use of Coun­try-by-Coun­try Re­ports The OECD has now pub­lished Guid­ance (avail­able here) on the ap­pro­pri­ate use of Coun­try-by-Coun­try Re­ports (‘Cb­CRs’) by na­tion­al tax au­thor­it­ies. This is in re­sponse to some val­id MNE con­cerns that tax au­thor­it­ies.
Clemens Grossmayer
19/09/2017
CMS Ad­vises in Aus­tria’s Largest Private Equity Trans­ac­tion...
Tower­Brook Cap­it­al Part­ners Ac­quires Sch­weig­hofer Fiber
05 Oct 17
Con­struc­tion law day 2017
14/09/2017
EU-US Pri­vacy Shield un­der High Scru­tiny
On 18 Septem­ber 2017, US Sec­ret­ary of Com­merce Wil­bur Ross and European Com­mis­sion­er Vĕra Jour­ova will launch the first an­nu­al re­view of the EU-US Pri­vacy Shield agree­ment (“Pri­vacy Shield”). The re­view will be a two-day ex­er­cise where European Com­mis­sion rep­res­ent­at­ives.
13/09/2017
CMS part­ners with Saudi Ar­a­bi­an law firm
27 Sep 17
We­bin­ar: Ne­go­ti­at­ing Asia deals
Why your con­tract might not be en­force­able in Asia...
13/09/2017
The ap­plic­a­tion of EU mer­ger con­trol cla­ri­fied: no EC no­ti­fic­a­tion...
In the first ever pre­lim­in­ary rul­ing on the EU mer­ger con­trol re­gime, the Court of Justice of the European Uni­on ("CJEU") brought much needed clar­ity on wheth­er the shift from sole con­trol to joint con­trol in an ex­ist­ing un­der­tak­ing is covered by the EU Mer­ger.
Published on September 1st 2017 on bestlawyers.com
Claims for An­ti­trust Dam­ages
07/09/2017
In­tel: no sub­sti­tute for ana­lys­is: Court re­news fo­cus on likely harm...
The long-awaited In­tel judg­ment on re­bates, re­leased on 6 Septem­ber, has es­tab­lished, fol­low­ing years of de­bate, a stand­ard for reg­u­lat­ory in­ter­ven­tion that re­quires a fo­cus on the likely ef­fects of in­di­vidu­al re­bate schemes in their par­tic­u­lar con­text.
08/09/2017
CMS Guide to In­ter­na­tion­al Trans­fer Pri­cing Doc­u­ment­a­tion
30/08/2017
The leg­al and reg­u­lat­ory chal­lenges of get­ting a bi­osim­il­ar product...
After a pharma view on bi­osim­il­ars was provided in the pre­vi­ous Ex­pert View column, a leg­al per­spect­ive is provided by Nick Beck­ett, man­aging part­ner at CMS Beijing and glob­al co-head of the firm­'s lifes­ci­ences sec­tor group.